In T-cell acute lymphoblastic leukemia (T-ALL), a 2–18 bp fragment is inserted into the noncoding intergenic region of the TAL1 gene to create a de novo binding site for MYB, thereby initiating SE formation and increasing TAL1 expression [33]. The gene discussed is TAL1; the disease is T-cell acute lymphoblastic leukemia.